Abstract |
Both (+)-[18F] flubatine and its enantiomer (-)-[18F] flubatine are radioligands for the neuroimaging of α4β2 nicotinic acetylcholine receptors (nAChRs) by positron emission tomography (PET). In a clinical study in patients with early Alzheimer's disease, (+)-[18F] flubatine ((+)-[18F]1) was examined regarding its metabolic fate, in particular by identification of degradation products detected in plasma and urine. The investigations included an in vivo study of (+)- flubatine ((+)-1) in pigs and structural elucidation of formed metabolites by LC-MS/MS. Incubations of (+)-1 and (+)-[18F]1 with human liver microsomes were performed to generate in vitro metabolites, as well as radiometabolites, which enabled an assignment of their structures by comparison of LC-MS/MS and radio-HPLC data. Plasma and urine samples taken after administration of (+)-[18F]1 in humans were examined by radio-HPLC and, on the basis of results obtained in vitro and in vivo, formed radiometabolites were identified.
|
Authors | Friedrich-Alexander Ludwig, Steffen Fischer, René Smits, Winnie Deuther-Conrad, Alexander Hoepping, Solveig Tiepolt, Marianne Patt, Osama Sabri, Peter Brust |
Journal | Molecules (Basel, Switzerland)
(Molecules)
Vol. 23
Issue 2
(Feb 20 2018)
ISSN: 1420-3049 [Electronic] Switzerland |
PMID | 29461507
(Publication Type: Journal Article)
|
Chemical References |
- Benzamides
- Bridged Bicyclo Compounds, Heterocyclic
- Receptors, Nicotinic
- fluoronorchloroepibatidine
|
Topics |
- Animals
- Benzamides
(administration & dosage, metabolism)
- Bridged Bicyclo Compounds, Heterocyclic
(administration & dosage, metabolism)
- Chromatography, Liquid
- Humans
- Metabolome
(genetics)
- Neuroimaging
- Positron-Emission Tomography
- Receptors, Nicotinic
(chemistry, isolation & purification)
- Swine
(blood, urine)
- Tandem Mass Spectrometry
|